These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 9305678)
1. Therapy of hepatitis C: patients with normal aminotransferase levels. Marcellin P; Lévy S; Erlinger S Hepatology; 1997 Sep; 26(3 Suppl 1):133S-136S. PubMed ID: 9305678 [TBL] [Abstract][Full Text] [Related]
2. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment. Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372 [TBL] [Abstract][Full Text] [Related]
3. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children. Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439 [TBL] [Abstract][Full Text] [Related]
4. Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA. Martinot-Peignoux M; Boyer N; Cazals-Hatem D; Pham BN; Gervais A; Le Breton V; Levy S; Degott C; Valla DC; Marcellin P Hepatology; 2001 Nov; 34(5):1000-5. PubMed ID: 11679971 [TBL] [Abstract][Full Text] [Related]
5. Natural history of hepatitis C and the impact of anti-viral therapy. Boyer N; Marcellin P Forum (Genova); 2000; 10(1):4-18. PubMed ID: 10717254 [TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up after successful interferon therapy of acute hepatitis C. Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091 [TBL] [Abstract][Full Text] [Related]
7. Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivo. Zeuzem S; Schmidt JM; Lee JH; Rüster B; Roth WK Hepatology; 1996 Feb; 23(2):366-71. PubMed ID: 8591865 [TBL] [Abstract][Full Text] [Related]
8. Interferon therapy in hemodialysis patients with chronic hepatitis C virus infection induces a high rate of long-term sustained virological and biochemical response. Espinosa M; Rodriguez M; Martin-Malo A; Alvarez de Lara MA; Gonzalez R; Lopez-Rubio F; de la Mata M; Aljama P Clin Nephrol; 2001 Mar; 55(3):220-6. PubMed ID: 11316242 [TBL] [Abstract][Full Text] [Related]
9. Alanine aminotransferase (ALT) levels in a normal population and interferon therapy in chronic hepatitis C patients with normal ALT. Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Yakabi S Hepatogastroenterology; 2003; 50(49):165-9. PubMed ID: 12630015 [TBL] [Abstract][Full Text] [Related]
10. Chronic hepatitis C virus infection in renal transplant: treatment and outcome. Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715 [TBL] [Abstract][Full Text] [Related]
11. Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy. Shiffman ML; Stewart CA; Hofmann CM; Contos MJ; Luketic VA; Sterling RK; Sanyal AJ J Infect Dis; 2000 Dec; 182(6):1595-601. PubMed ID: 11069229 [TBL] [Abstract][Full Text] [Related]
12. Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels. Carreño V; Pardo M; López-Alcorocho JM; Rodríguez-Iñigo E; Bartolomé J; Castillo I J Infect Dis; 2006 Jul; 194(1):53-60. PubMed ID: 16741882 [TBL] [Abstract][Full Text] [Related]
13. Intrahepatic hepatitis C RNA levels do not correlate with degree of liver injury in patients with chronic hepatitis C. McGuinness PH; Bishop GA; Painter DM; Chan R; McCaughan GW Hepatology; 1996 Apr; 23(4):676-87. PubMed ID: 8666317 [TBL] [Abstract][Full Text] [Related]
14. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy. Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189 [TBL] [Abstract][Full Text] [Related]
15. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Silini E; Bono F; Cividini A; Cerino A; Bruno S; Rossi S; Belloni G; Brugnetti B; Civardi E; Salvaneschi L Hepatology; 1995 Feb; 21(2):285-90. PubMed ID: 7843695 [TBL] [Abstract][Full Text] [Related]
16. Hepatic and extrahepatic HCV RNA strands in chronic hepatitis C: different patterns of response to interferon treatment. Gil B; Qian C; Riezu-Boj JI; Civeira MP; Prieto J Hepatology; 1993 Nov; 18(5):1050-4. PubMed ID: 8225209 [TBL] [Abstract][Full Text] [Related]
17. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels. Puoti C; Magrini A; Stati T; Rigato P; Montagnese F; Rossi P; Aldegheri L; Resta S Hepatology; 1997 Dec; 26(6):1393-8. PubMed ID: 9397976 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis C viral quasispecies and liver damage in patients with chronic hepatitis C virus infection. Hayashi J; Kishihara Y; Yamaji K; Furusyo N; Yamamoto T; Pae Y; Etoh Y; Ikematsu H; Kashiwagi S Hepatology; 1997 Mar; 25(3):697-701. PubMed ID: 9049221 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy. Larghi A; Tagger A; Crosignani A; Ribero ML; Bruno S; Portera G; Battezzati PM; Maggioni M; Fasola M; Zuin M; Podda M J Med Virol; 1998 May; 55(1):7-11. PubMed ID: 9580879 [TBL] [Abstract][Full Text] [Related]
20. Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients with chronic hepatitis C unresponsive to alpha-interferon. Mazzoran L; Grassi G; Giacca M; Gerini U; Baracetti S; Fanni-Canelles M; Zorat F; Pozzato G Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):338-42. PubMed ID: 9476188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]